Home/Filings/4/0001104659-23-009972
4//SEC Filing

Eisenstadt Richard I 4

Accession 0001104659-23-009972

CIK 0001326190other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:09 PM ET

Size

5.2 KB

Accession

0001104659-23-009972

Insider Transaction Report

Form 4
Period: 2023-01-31
Eisenstadt Richard I
Chief Financial Officer
Transactions
  • Award

    Common Stock, par value $0.0001

    2023-01-31$10.21/sh+1,172$11,96412,010 total
Footnotes (2)
  • [F1]These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2022 through January 31, 2023.
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the opening price of the issuer's common stock on August 1, 2022.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001515806

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:09 PM ET
Size
5.2 KB